Healthcare software provider Voluntis has raised $29 million (€20.75 million) in its fourth financing. This round is classified among the biggest fundings in the m-health industry for htis year, according to InsuranceNewsNet.

Voluntis founder and chief executive officer (CEO) Pierre Leurent said: "This strong investor syndicate is recognition of our relentless work to design the next-generation therapeutic solutions that combine digital and medical expertise in order to help solve some key daily problems of patients and care providers. This round is pivotal to grow Voluntis. I would like to thank the existing investors for their continued support and welcome the new investors who have stepped up to help us meet the exciting challenges ahead."

The lead investors in the said round were Bpifrance Large Venture and Vesalius Biocapital. Qualcomm Ventures and existing investors CapDecisif Management, Sham, and CM-CIC Capital Innovation also contributed to the financing, the report detailed.

Voluntis will use the new capital to speed up the development of its diabetes management softare and other chronic disease management programs. It will also use the funding to beef up its operations in the US, InsuranceNewsNet reported.